Actively Recruiting
VIrtual Reality Glasses Use to Improve Lateropulsion and the Post-stroke Postural Vertical
Led by University Hospital, Grenoble · Updated on 2025-05-21
40
Participants Needed
1
Research Sites
258 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Grenoble
Lead Sponsor
F
Fondation Paul Bennetot
Collaborating Sponsor
AI-Summary
What this Trial Is About
VIRGIL is a monocentric interventional study aiming to investigate the effect of immersion in a virtual tilted room on modulation of the verticality representation (postural vertical \[PV\] and visual vertical \[VV\]), which in turn might affect body orientation (head and trunk). To this end, the investigators will conduct a within-person randomized trial including post-stroke patients and healthy participants.
CONDITIONS
Official Title
VIrtual Reality Glasses Use to Improve Lateropulsion and the Post-stroke Postural Vertical
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Stroke participants hospitalized in neurorehabilitation with hemisphere stroke (right or left)
- Stroke occurred less than 6 months ago
- Presence of lateropulsion with Scale for Contraversive Pushing (SCP) greater than 0.5
- Healthy participants with no history of stroke or other neurological diseases
- Healthy participants with no balance disorders
- Healthy participants with no history of vestibular or dizziness disorders
You will not qualify if you...
- History of psychiatric disorders
- Nyctophobia
- Advanced heart failure
- Severe trunk deformation with lateral deviation of C7 greater than 30 mm due to causes other than stroke
- History of postural disorders unrelated to stroke
- Stroke participants with medical instability preventing assessment
- Stroke participants with comprehension deficits (Boston Diagnostic Aphasia Examination gravity score 3)
- Stroke participants with history of vestibular or dizziness disorders
- Stroke participants with prior neurological history affecting balance
- Stroke participants unable to understand and follow simple orders
- Stroke participants with severe untreated depression (Aphasic Depression Rating Scale score 15)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Grenoble
Grenoble, France, 38000
Actively Recruiting
Research Team
D
Dominic Pérennou
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here